RDNT Revenue Breakdown
RadNet, Inc. (RDNT). Quarter ended 2026-06-30 · 10-Q · every retained filed quarter remains available.
- 2025-12-31: Others Not split by product in the filing$2.04B100.00%; Total revenue $2.04B.
- 2024-12-31: Others Not split by product in the filing$1.83B100.00%; Total revenue $1.83B.
- 2023-12-31: Others Not split by product in the filing$1.62B100.00%; Total revenue $1.62B.
- 2022-12-31: Others Not split by product in the filing$1.43B100.00%; Total revenue $1.43B.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $2.04B 100.00% | $2.04B |
| 2024-12-31 | Not split by product in the filing $1.83B 100.00% | $1.83B |
| 2023-12-31 | Not split by product in the filing $1.62B 100.00% | $1.62B |
| 2022-12-31 | Not split by product in the filing $1.43B 100.00% | $1.43B |
| 2021-12-31 | Not split by product in the filing $1.32B 100.00% | $1.32B |
| 2020-12-31 | Not split by product in the filing $1.07B 100.00% | $1.07B |
| 2019-12-31 | Not split by product in the filing $1.15B 100.00% | $1.15B |
| 2018-12-31 | Not split by product in the filing $975.15M 100.00% | $975.15M |
| 2017-12-31 | Not split by product in the filing $922.19M 100.00% | $922.19M |
| 2016-12-31 | Not split by product in the filing $884.53M 100.00% | $884.53M |
| 2015-12-31 | Not split by product in the filing $809.63M 100.00% | $809.63M |
| 2014-12-31 | Not split by product in the filing $717.57M 100.00% | $717.57M |
| 2013-12-31 | Not split by product in the filing $702.99M 100.00% | $702.99M |
| 2012-12-31 | Not split by product in the filing $85.04M 100.00% | $85.04M |
| 2011-12-31 | Not split by product in the filing $76.08M 100.00% | $76.08M |
| 2010-12-31 | Not split by product in the filing $76.94M 100.00% | $76.94M |
| 2009-12-31 | Not split by product in the filing $527.62M 100.00% | $527.62M |
Each quarter (3 month)
| Quarter end | Health Care, Patient Service | Capitation Arrangements | Others | Total revenue |
|---|---|---|---|---|
| 2026-06-30 | $592.59M 95.16% | $30.13M 4.84% | $622.72M | |
| 2026-03-31 | Not split by product $575.63M 100.00% | $575.63M | ||
| 2025-12-31 | Not split by product $547.71M 100.00% | $547.71M | ||
| 2025-09-30 | Not split by product $522.87M 100.00% | $522.87M | ||
| 2025-06-30 | $468.06M 93.95% | $30.17M 6.05% | $498.23M | |
| 2025-03-31 | Not split by product $471.40M 100.00% | $471.40M | ||
| 2024-12-31 | Not split by product $477.10M 100.00% | $477.10M | ||
| 2024-09-30 | Not split by product $461.14M 100.00% | $461.14M | ||
| 2024-06-30 | Not split by product $459.71M 100.00% | $459.71M | ||
| 2024-03-31 | Not split by product $431.71M 100.00% | $431.71M | ||
| 2023-12-31 | Not split by product $420.38M 100.00% | $420.38M | ||
| 2023-09-30 | Not split by product $401.97M 100.00% | $401.97M | ||
| 2023-06-30 | Not split by product $403.71M 100.00% | $403.71M | ||
| 2023-03-31 | Not split by product $390.56M 100.00% | $390.56M | ||
| 2022-12-31 | Not split by product $383.88M 100.00% | $383.88M | ||
| 2022-09-30 | Not split by product $350.04M 100.00% | $350.04M | ||
| 2022-06-30 | Not split by product $354.38M 100.00% | $354.38M | ||
| 2022-03-31 | Not split by product $341.77M 100.00% | $341.77M | ||
| 2021-12-31 | Not split by product $333.15M 100.00% | $333.15M | ||
| 2021-09-30 | Not split by product $332.69M 100.00% | $332.69M | ||
| 2021-06-30 | Not split by product $333.92M 100.00% | $333.92M | ||
| 2021-03-31 | Not split by product $315.32M 100.00% | $315.32M | ||
| 2020-12-31 | Not split by product $307.94M 100.00% | $307.94M | ||
| 2020-09-30 | Not split by product $291.78M 100.00% | $291.78M | ||
| 2020-06-30 | Not split by product $190.57M 100.00% | $190.57M | ||
| 2020-03-31 | Not split by product $281.56M 100.00% | $281.56M | ||
| 2019-12-31 | Not split by product $300.84M 100.00% | $300.84M | ||
| 2019-09-30 | Not split by product $292.69M 100.00% | $292.69M | ||
| 2019-06-30 | Not split by product $289.10M 100.00% | $289.10M | ||
| 2019-03-31 | Not split by product $271.55M 100.00% | $271.55M | ||
| 2018-12-31 | Not split by product $257.21M 100.00% | $257.21M | ||
| 2018-09-30 | Not split by product $242.15M 100.00% | $242.15M | ||
| 2018-06-30 | Not split by product $244.40M 100.00% | $244.40M | ||
| 2018-03-31 | Not split by product $231.39M 100.00% | $231.39M | ||
| 2017-12-31 | Not split by product $235.55M 100.00% | $235.55M | ||
| 2017-09-30 | Not split by product $227.61M 100.00% | $227.61M | ||
| 2017-06-30 | Not split by product $230.01M 100.00% | $230.01M | ||
| 2017-03-31 | Not split by product $229.01M 100.00% | $229.01M | ||
| 2016-12-31 | Not split by product $224.94M 100.00% | $224.94M | ||
| 2016-09-30 | Not split by product $224.64M 100.00% | $224.64M | ||
| 2016-06-30 | Not split by product $218.56M 100.00% | $218.56M | ||
| 2016-03-31 | Not split by product $216.39M 100.00% | $216.39M | ||
| 2015-12-31 | Not split by product $215.71M 100.00% | $215.71M | ||
| 2015-09-30 | Not split by product $208.37M 100.00% | $208.37M | ||
| 2015-06-30 | Not split by product $204.29M 100.00% | $204.29M | ||
| 2015-03-31 | Not split by product $181.27M 100.00% | $181.27M | ||
| 2014-12-31 | Not split by product $185.55M 100.00% | $185.55M | ||
| 2014-09-30 | Not split by product $98.00M 100.00% | $98.00M | ||
| 2014-06-30 | Not split by product $179.08M 100.00% | $179.08M | ||
| 2014-03-31 | Not split by product $168.88M 100.00% | $168.88M | ||
| 2013-12-31 | Not split by product $178.34M 100.00% | $178.34M | ||
| 2013-09-30 | Not split by product $98.30M 100.00% | $98.30M | ||
| 2013-06-30 | Not split by product $22.93M 100.00% | $22.93M | ||
| 2013-03-31 | Not split by product $22.28M 100.00% | $22.28M | ||
| 2012-12-31 | Not split by product -$402.78M 100.00% | -$402.78M | ||
| 2012-09-30 | Not split by product $160.45M 100.00% | $160.45M | ||
| 2012-06-30 | Not split by product $20.88M 100.00% | $20.88M | ||
| 2012-03-31 | Not split by product $21.08M 100.00% | $21.08M | ||
| 2011-12-31 | Not split by product $20.09M 100.00% | $20.09M | ||
| 2011-09-30 | Not split by product $143.02M 100.00% | $143.02M | ||
| 2011-06-30 | Not split by product $147.70M 100.00% | $147.70M | ||
| 2011-03-31 | Not split by product $139.05M 100.00% | $139.05M | ||
| 2010-12-31 | Not split by product $148.59M 100.00% | $148.59M | ||
| 2010-09-30 | Not split by product $140.09M 100.00% | $140.09M | ||
| 2010-06-30 | Not split by product $138.95M 100.00% | $138.95M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |